Cerebrospinal Fluid (CSF) Management Market is expected to grow at a CAGR of 5.22% during the forecast period. Global Cerebrospinal Fluid (CSF) Management Market is expected to reach US$ 3.02 Bn. by 2029.Cerebrospinal Fluid (CSF) Management Market Overview:
Cerebrospinal fluid (CSF) is a colourless fluid produced by a group of cells that provides mechanical and immunological protection to the brain. It is located in the brain and spinal cord. CSF shunts and CSF drainage systems are two management devices that regulate the movement of CSF in the body away from the ventricles in a regulated manner, preventing abnormal CSF accumulation and hydrocephalus.To know about the Research Methodology :- Request Free Sample Report
Cerebrospinal Fluid (CSF) Management Market Dynamics:
Rising prevalence of Hydrocephalus globally and it results in increased number of shunting procedures majorly drives the market growth. A large population globally suffers from hydrocephalus. More than 1 million people in the United States are said to have hydrocephalus, states the Hydrocephalus Association. Similarly, 700,000 senior citizens in the United States suffer from normal pressure hydrocephalus (NPH). In addition, the increasing geriatric population and the rising number of neurological disorders are expected to fuel the demand in the coming years. The demand for cerebrospinal fluid (CSF) devices is being driven by an increase in the number of brain surgeries. Shunts are instruments used in the CSF process that ensure that any cerebrospinal fluid collected near the brain is drained out. CSF devices play an important role in the treatment of traumatic brain injury (TBI). TBI is one of the leading causes of death in the United States, with 1.5 to 2 million adults and children suffering from the condition each year. The latest trend in the cerebrospinal fluid devices market is to implement new and improved sensors, which could provide the market the boost to increase its growth rate while also improving the quality of the diagnosis. CSF devices are currently classified as class II devices by the US Food and Drug Administration (FDA). Before these devices can be authorized, according to section 21, subsection 510K, a specific protocol must be followed. Furthermore, the disposable incomes, increased demand for minimally invasive surgeries, the growth of healthcare infrastructure, and advanced devices are expected to propel the market forward over the forecasted period. The report has profiled sixteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.Cerebrospinal Fluid (CSF) Management Market Segment Analysis:
The Global Cerebrospinal Fluid (CSF) Management Market is segmented on the basis of Product and End-Users.
Based on Product, the CSF shunts segment is expected to account for dominant market share during the forecast period. Shunts are the conventional method used, due to which the segment accounted for the largest market share XX% of the cerebrospinal fluid management market in 2019. Other factors contributing to the segment growth are the increase in the number of revision shunt surgeries due to shunt failure and infection, as well as an increase in the number of shunting procedures performed globally. Shunts have been found to be useful in the safe diversion of CSF away from the fluid compartments of the central nervous system (CNS). It allows fluid to flow in a different direction. Furthermore, technological advances in these devices to tackle biocompatibility, infection, and fouling are expected to contribute to the segment's growth in forecast years. Drainage devices are expected to rise at the fastest rate during the forecast period, owing to their broad application in monitoring a variety of CSF-related conditions. Furthermore, research in this segment to overcome the shortcomings of existing devices is expected to accelerate the segment's growth. BeckerSmith Medical, Inc. recently launched the first integrated CSF drain monitoring device, which helps to reduce ICU workload and duration of stay.Cerebrospinal Fluid (CSF) Management Market Regional Insights:
North America dominates the global Cerebrospinal Fluid (CSF) Management market.
The North American region is projected to generate the most revenue over the forecast period as a result of rising approvals by the US FDA for new drugs and the growing geriatric population suffering from nervous disorders. APAC region is expected to witness lucrative growth during forecast period. Due to growing awareness of neurological disorders and treatment options in the area, as well as an increase in the incidence of stroke disease, Asia Pacific is expected to rise at a faster rate over the forecast period. The growth of Original Equipment Manufacturers (OEMs) into emerging economies to tap the potential market is expected to fuel growth in this area. Due to the medical tourism in India and other Asia Pacific countries, the high prevalence of congenital hydrocephalus in China and the growing geriatric population in Japan, Asia Pacific will hold the largest share of the market. The report also helps in understanding Global Cerebrospinal Fluid (CSF) Management Market dynamics, structure by analyzing the market segments and project the Global Cerebrospinal Fluid (CSF) Management Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Cerebrospinal Fluid (CSF) Management Market make the report investor’s guide.Cerebrospinal Fluid (CSF) Management Market, Key Developments:
• FlowSense, a portable, non-invasive flow monitor, received the FDA for Breakthrough System Designation in June 2020. This device is developed by Rhaeos, Inc. (Rhaeos), a private medical technology company focusing on addressing the unmet clinical need for hydrocephalus patients due to excess cerebrospinal fluid.Cerebrospinal Fluid (CSF) Management Market Scope: Inquire before buying
Cerebrospinal Fluid (CSF) Management Market Report Coverage Details Base Year: 2022 Forecast Period: 2023-2029 Historical Data: 2017 to 2022 Market Size in 2022: US $ 2.12 Bn. Forecast Period 2023 to 2029 CAGR: 5.22% Market Size in 2029: US $ 3.02 Bn. Segments Covered: by Product • CSF Shunts • CSF Drainage by End users • Pediatric • Adult • Geriatric Cerebrospinal Fluid (CSF) Management Market, by Region
• North America (United States, Canada and Mexico) • Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe) • Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC) • Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A) • South America (Brazil, Argentina Rest of South America)Cerebrospinal Fluid (CSF) Management Market Key Players:
• Medtronic plc • B. Braun Melsungen AG • DePuy Synthes • Spiegelberg GmbH & Co. KG • Sophysa S.A. • Integra LifeSciences • Magstim • Johnson & Johnson Services • Beckersmith Medical, Inc • Elekta AB • Phoenix Biomedical Corp. • Natus Medical Incorporated • Dispomedica GmbH • Argi Grup • Möller Medical GmbH • Wellong Instruments Co., Ltd. Frequently Asked Questions: 1. Which region has the largest share in Global Cerebrospinal Fluid (CSF) Management Market? Ans: North America region held the highest share in 2022. 2. What is the growth rate of Global Cerebrospinal Fluid (CSF) Management Market? Ans: The Global Cerebrospinal Fluid (CSF) Management Market is growing at a CAGR of 5.22% during forecasting period 2023-2029. 3. What is scope of the Global Cerebrospinal Fluid (CSF) Management Market report? Ans: Global Cerebrospinal Fluid (CSF) Management Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period. 4. Who are the key players in Global Cerebrospinal Fluid (CSF) Management Market? Ans: The important key players in the Global Cerebrospinal Fluid (CSF) Management Market are – Medtronic plc, B. Braun Melsungen AG, DePuy Synthes, Spiegelberg GmbH & Co. KG, Sophysa S.A., Integra LifeSciences, Magstim, Johnson & Johnson Services, Beckersmith Medical, Inc, Elekta AB, Phoenix Biomedical Corp., Natus Medical Incorporated, Dispomedica GmbH, Argi Grup, Möller Medical GmbH, Wellong Instruments Co., Ltd. 5. What is the study period of this Market? Ans: The Global Cerebrospinal Fluid (CSF) Management Market is studied from 2022 to 2029.
1. Preface 1.1. Market Definition and Key Research Objectives 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Cerebrospinal Fluid (CSF) Management Market Size, by Market Value (US$ Mn) 3.1. Global Market Segmentation 3.2. Global Market Segmentation Share Analysis, 2019 3.2.1. Global 3.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 3.3. Geographical Snapshot of the Cerebrospinal Fluid (CSF) Management Market 3.4. Geographical Snapshot of the Cerebrospinal Fluid (CSF) Management Market, By Manufacturer share 4. Global Cerebrospinal Fluid (CSF) Management Market Overview, 2022-2029 4.1. Market Dynamics 4.1.1. Drivers 4.1.1.1. Global 4.1.1.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.2. Restraints 4.1.2.1. Global 4.1.2.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.3. Opportunities 4.1.3.1. Global 4.1.3.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.4. Challenges 4.1.4.1. Global 4.1.4.2. By Region (North America, Europe, Asia Pacific, South America, Middle East Africa) 4.1.5. Industry Trends and Emerging Technologies 4.1.6. Porters Five Forces Analysis 4.1.6.1. Threat of New Entrants 4.1.6.2. Bargaining Power of Buyers/Consumers 4.1.6.3. Bargaining Power of Suppliers 4.1.6.4. Threat of Substitute Products 4.1.6.5. Intensity of Competitive Rivalry 4.1.7. Value Chain Analysis 4.1.8. Technological Roadmap 4.1.9. Regulatory landscape 4.1.10. Impact of the Covid-19 Pandemic on the Global Cerebrospinal Fluid (CSF) Management Market 5. Supply Side and Demand Side Indicators 6. Global Cerebrospinal Fluid (CSF) Management Market Analysis and Forecast, 2022-2029 6.1. Global Cerebrospinal Fluid (CSF) Management Market Size & Y-o-Y Growth Analysis. 7. Global Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 7.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 7.1.1. CSF Shunts 7.1.2. CSF Drainage 7.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 7.2.1. Pediatric 7.2.2. Adult 7.2.3. Geriatric 8. Global Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, By Region 8.1. Market Size (Value) Estimates & Forecast By Region, 2022-2029 8.1.1. North America 8.1.2. Europe 8.1.3. Asia-Pacific 8.1.4. Middle East & Africa 8.1.5. South America 9. North America Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 9.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 9.1.1. CSF Shunts 9.1.2. CSF Drainage 9.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 9.2.1. Pediatric 9.2.2. Adult 9.2.3. Geriatric 10. North America Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, By Country 10.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 10.1.1. US 10.1.2. Canada 10.1.3. Mexico 11. U.S. Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 11.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 11.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 12. Canada Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 12.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 12.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 13. Mexico Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 13.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 13.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 14. Europe Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 14.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 14.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 15. Europe Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, By Country 15.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 15.1.1. U.K 15.1.2. France 15.1.3. Germany 15.1.4. Italy 15.1.5. Spain 15.1.6. Sweden 15.1.7. CIS Countries 15.1.8. Rest of Europe 16. U.K. Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 16.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 16.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 17. France Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 17.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 17.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 18. Germany Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 18.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 18.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 19. Italy Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 19.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 19.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 20. Spain Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 20.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 20.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 21. Sweden Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 21.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 21.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 22. CIS Countries Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 22.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 22.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 23. Rest of Europe Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 23.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 23.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 24. Asia Pacific Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 24.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 24.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 25. Asia Pacific Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, by Country 25.1. Market Size (Value) Estimates & Forecast By Country, 2022-2029 25.1.1. China 25.1.2. India 25.1.3. Japan 25.1.4. South Korea 25.1.5. Australia 25.1.6. ASEAN 25.1.7. Rest of Asia Pacific 26. China Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 26.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 26.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 27. India Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 27.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 27.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 28. Japan Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 28.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 28.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 29. South Korea Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 29.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 29.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 30. Australia Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 30.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 30.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 31. ASEAN Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 31.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 31.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 32. Rest of Asia Pacific Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 32.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 32.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 33. Middle East Africa Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 33.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 33.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 34. Middle East Africa Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, by Country 34.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 34.1.1. South Africa 34.1.2. GCC Countries 34.1.3. Egypt 34.1.4. Nigeria 34.1.5. Rest of ME&A 35. South Africa Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 35.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 35.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 36. GCC Countries Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 36.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 36.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 37. Egypt Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 37.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 37.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 38. Nigeria Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 38.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 38.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 39. Rest of ME&A Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 39.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 39.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 40. South America Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 40.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 40.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 41. South America Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, by Country 41.1. Market Size (Value) Estimates & Forecast by Country, 2022-2029 41.1.1. Brazil 41.1.2. Argentina 41.1.3. Rest of South America 42. Brazil Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 42.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 42.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 43. Argentina Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 43.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 43.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 44. Rest of South America Cerebrospinal Fluid (CSF) Management Market Analysis and Forecasts, 2022-2029 44.1. Market Size (Value) Estimates & Forecast By Product, 2022-2029 44.2. Market Size (Value) Estimates & Forecast By End users, 2022-2029 45. Competitive Landscape 45.1. Geographic Footprint of Major Players in the Global Cerebrospinal Fluid (CSF) Management Market 45.2. Competition Matrix 45.2.1. Competitive Benchmarking of Key Players By Price, Presence, Market Share, Applications and R&D Investment 45.2.2. New Product Launches and Product Enhancements 45.2.3. Market Consolidation 45.2.3.1. M&A by Regions, Investment and Verticals 45.2.3.2. M&A, Forward Integration and Backward Integration 45.2.3.3. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements 45.3. Company Profile : Key Players 45.3.1. Medtronic plc 45.3.1.1. Company Overview 45.3.1.2. Financial Overview 45.3.1.3. Geographic Footprint 45.3.1.4. Product Portfolio 45.3.1.5. Business Strategy 45.3.1.6. Recent Developments 45.3.2. B. Braun Melsungen AG 45.3.3. DePuy Synthes 45.3.4. Spiegelberg GmbH & Co. KG 45.3.5. Sophysa S.A. 45.3.6. Integra LifeSciences 45.3.7. Magstim 45.3.8. Johnson & Johnson Services 45.3.9. Beckersmith Medical, Inc 45.3.10. Elekta AB 45.3.11. Phoenix Biomedical Corp. 45.3.12. Natus Medical Incorporated 45.3.13. Dispomedica GmbH 45.3.14. Argi Grup 45.3.15. Möller Medical GmbH 45.3.16. Wellong Instruments Co., Ltd. 46. Primary Key Insights